Vericel Corporation (VCEL)

$38.56 -2.17 (-5.33%)
Market Cap 2.06B
Revenue (ttm) 237.22M
Net Income (ttm) 10.36M
EPS (ttm) N/A
PE Ratio 168.13
Forward PE 66.81
Profit Margin 4.37%
Debt to Equity Ratio 0.00
Volume 787,600
Avg Vol 644,230
Day's Range N/A - N/A
Shares Out 50.57M
Stochastic %K 51%
Beta 1.17
Analysts Strong Sell
Price Target $55.00

Company Profile

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 588 5555
Fax: 617 588 5554
Address:
64 Sidney Street, Cambridge, United States
Pro_From_Dover
Pro_From_Dover Jan. 9 at 8:58 PM
$VCEL typical POS bs…. A bit of a run up, then unexplainable but expected 5+% drop.
0 · Reply
JHR
JHR Jan. 8 at 5:53 PM
$RCEL Who is going to acquire $RCEL in late 2026? $SOLV $MDXG $VCEL
0 · Reply
Groyper69
Groyper69 Jan. 7 at 11:04 PM
$VCEL Raging hard on to start the year!!! 😍😛
0 · Reply
JohnPDaly
JohnPDaly Jan. 2 at 10:16 PM
$MDWD $VCEL
0 · Reply
copperhat
copperhat Jan. 2 at 8:49 PM
$VCEL so much for a nice start to the new year
3 · Reply
copperhat
copperhat Jan. 2 at 6:43 PM
$VCEL vomit
0 · Reply
copperhat
copperhat Jan. 2 at 6:05 PM
$VCEL this is so limp, it's depressing
0 · Reply
copperhat
copperhat Jan. 2 at 4:02 PM
$VCEL 1.5 hr into the new year and I'm already down $1K
0 · Reply
WallStWireAds
WallStWireAds Jan. 2 at 2:09 PM
$VCEL $MDWD https://www.benzinga.com/content/49665728/mediwounds-enzymatic-burn-therapy-deployed-after-new-years-tragedy-in-switzerland-nasdaq-mdwd
0 · Reply
copperhat
copperhat Dec. 31 at 9:01 PM
$VCEL sorry, back in at 36 at 12:59:50. Drop imminent.
0 · Reply
Latest News on VCEL
Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Jan 6, 2026, 8:30 AM EST - 4 days ago

Vericel to Present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Nov 14, 2025, 8:30 AM EST - 2 months ago

Vericel to Present at the Stephens Annual Investment Conference on Thursday, November 20, 2025

Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 2:46 PM EST - 2 months ago

Vericel Corporation (VCEL) Q3 2025 Earnings Call Transcript

Vericel Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 7:55 AM EST - 2 months ago

Vericel Reports Third Quarter 2025 Financial Results

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Aug 28, 2025, 8:30 AM EDT - 4 months ago

Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Jul 31, 2025, 3:10 PM EDT - 5 months ago

Vericel Corporation (VCEL) Q2 2025 Earnings Call Transcript

Vericel Reports Second Quarter 2025 Financial Results

Jul 31, 2025, 8:08 AM EDT - 5 months ago

Vericel Reports Second Quarter 2025 Financial Results

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Jul 17, 2025, 8:30 AM EDT - 6 months ago

Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025

Vericel Corporation: Moving From Sell To Neutral

Jun 12, 2025, 10:23 AM EDT - 7 months ago

Vericel Corporation: Moving From Sell To Neutral

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Jun 10, 2025, 8:30 AM EDT - 7 months ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

May 8, 2025, 1:52 PM EDT - 8 months ago

Vericel Corporation (VCEL) Q1 2025 Earnings Conference Call Transcript

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

May 8, 2025, 7:55 AM EDT - 8 months ago

Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

May 7, 2025, 8:30 AM EDT - 8 months ago

Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 8:30 AM EDT - 9 months ago

Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025

Vericel: Scalable Growth With Strong Margins

Mar 5, 2025, 11:56 PM EST - 11 months ago

Vericel: Scalable Growth With Strong Margins

Vericel to Present at Multiple Upcoming Investor Conferences

Mar 4, 2025, 8:30 AM EST - 11 months ago

Vericel to Present at Multiple Upcoming Investor Conferences

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 1:05 PM EST - 11 months ago

Vericel Corporation (VCEL) Q4 2024 Earnings Conference Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 27, 2025, 7:54 AM EST - 11 months ago

Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 8:30 AM EST - 11 months ago

Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Jan 15, 2025, 8:52 AM EST - 1 year ago

Applied Digital, Vericel, Calavo Growers And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

APLD CVGW

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Jan 14, 2025, 4:05 PM EST - 1 year ago

Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets

Vericel Corporation: Hard To Justify Current Valuation

Dec 19, 2024, 12:50 PM EST - 1 year ago

Vericel Corporation: Hard To Justify Current Valuation

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Nov 7, 2024, 1:52 PM EST - 1 year ago

Vericel Corporation (VCEL) Q3 2024 Earnings Conference Call Transcript

Vericel Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 7:55 AM EST - 1 year ago

Vericel Reports Third Quarter 2024 Financial Results

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Third-Quarter 2024 Financial Results on November 7, 2024

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Aug 29, 2024, 9:17 AM EDT - 1 year ago

Vericel to Present at the Morgan Stanley Global Healthcare Conference on Friday, September 6, 2024

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Aug 26, 2024, 7:45 AM EDT - 1 year ago

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Aug 15, 2024, 4:05 PM EDT - 1 year ago

Vericel Announces FDA Approval of NexoBrid for the Treatment of Pediatric Patients with Severe Thermal Burns

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Aug 7, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 3:58 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q2 2024 Earnings Call Transcript

Vericel Reports Second Quarter 2024 Financial Results

Aug 1, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports Second Quarter 2024 Financial Results

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Jul 22, 2024, 8:30 AM EDT - 1 year ago

Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report Second-Quarter 2024 Financial Results on August 1, 2024

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Jun 11, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

May 22, 2024, 8:30 AM EDT - 1 year ago

Vericel to Present at the Leerink Partners Healthcare Crossroads Conference on Wednesday, May 29, 2024

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

May 8, 2024, 2:36 PM EDT - 1 year ago

Vericel Corporation (VCEL) Q1 2024 Earnings Call Transcript

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

May 8, 2024, 7:55 AM EDT - 1 year ago

Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Apr 24, 2024, 8:30 AM EDT - 1 year ago

Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Feb 29, 2024, 11:39 AM EST - 2 years ago

Vericel Corporation (VCEL) Q4 2023 Earnings Call Transcript

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Feb 29, 2024, 7:55 AM EST - 2 years ago

Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Feb 27, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Feb 15, 2024, 8:30 AM EST - 2 years ago

Vericel to Report Fourth-Quarter and Full-Year 2023 Financial Results on February 29, 2024

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Feb 5, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Jan 9, 2024, 7:55 AM EST - 2 years ago

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Jan 3, 2024, 8:30 AM EST - 2 years ago

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 2:43 PM EST - 2 years ago

Vericel Corporation (VCEL) Q3 2023 Earnings Call Transcript

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Nov 8, 2023, 7:55 AM EST - 2 years ago

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

Vericel to Present at the Stephens Annual Investment Conference

Nov 7, 2023, 8:30 AM EST - 2 years ago

Vericel to Present at the Stephens Annual Investment Conference

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Oct 25, 2023, 8:30 AM EDT - 2 years ago

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Sep 28, 2023, 8:30 AM EDT - 2 years ago

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

Pro_From_Dover
Pro_From_Dover Jan. 9 at 8:58 PM
$VCEL typical POS bs…. A bit of a run up, then unexplainable but expected 5+% drop.
0 · Reply
JHR
JHR Jan. 8 at 5:53 PM
$RCEL Who is going to acquire $RCEL in late 2026? $SOLV $MDXG $VCEL
0 · Reply
Groyper69
Groyper69 Jan. 7 at 11:04 PM
$VCEL Raging hard on to start the year!!! 😍😛
0 · Reply
JohnPDaly
JohnPDaly Jan. 2 at 10:16 PM
$MDWD $VCEL
0 · Reply
copperhat
copperhat Jan. 2 at 8:49 PM
$VCEL so much for a nice start to the new year
3 · Reply
copperhat
copperhat Jan. 2 at 6:43 PM
$VCEL vomit
0 · Reply
copperhat
copperhat Jan. 2 at 6:05 PM
$VCEL this is so limp, it's depressing
0 · Reply
copperhat
copperhat Jan. 2 at 4:02 PM
$VCEL 1.5 hr into the new year and I'm already down $1K
0 · Reply
WallStWireAds
WallStWireAds Jan. 2 at 2:09 PM
$VCEL $MDWD https://www.benzinga.com/content/49665728/mediwounds-enzymatic-burn-therapy-deployed-after-new-years-tragedy-in-switzerland-nasdaq-mdwd
0 · Reply
copperhat
copperhat Dec. 31 at 9:01 PM
$VCEL sorry, back in at 36 at 12:59:50. Drop imminent.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 31 at 5:47 PM
$VCEL Current Stock Price: $36.50 Contracts to trade: $35 VCEL Jan 16 2026 Call Entry: $0.60 Exit: $0.95 ROI: 58% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 31 at 1:25 AM
$VCEL Current Stock Price: $36.77 Contracts to trade: $35 VCEL Jan 16 2026 Call Entry: $2.25 Exit: $2.89 ROI: 29% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Pro_From_Dover
Pro_From_Dover Dec. 30 at 8:56 PM
$VCEL a turd of epic proportions
0 · Reply
Pro_From_Dover
Pro_From_Dover Dec. 30 at 2:52 PM
$VCEL limp freakin dik.
0 · Reply
FiscalResearchPilot
FiscalResearchPilot Dec. 27 at 8:11 AM
$VCEL Risk tolerance remains selective and tied closely to execution credibility. Competitive advantages must begin to appear in core metrics. Sustained improvement may validate the long‑term thesis. Execution quality becomes the defining catalyst from here.
0 · Reply
NXXT
NXXT Dec. 26 at 7:00 PM
$VCEL biotech holding base watching continuation
0 · Reply
CapacityCaptain
CapacityCaptain Dec. 26 at 9:21 AM
$VCEL This name increasingly trades on execution rhythm rather than speculation about possibilities. Operational consistency must improve quarter by quarter. Operational wins could gradually shift expectations upward. Ultimately, this is a case where delivery will decide trajectory.
0 · Reply
copperhat
copperhat Dec. 24 at 8:51 PM
$VCEL wow, I started 2025 holding at over $55
0 · Reply
Doozio
Doozio Dec. 23 at 11:48 PM
$VCEL is this 🐷 gonna start rocking with Roger out of the tightness because it was always ENTA 🐒🍌🧠⏰♾️
0 · Reply
copperhat
copperhat Dec. 22 at 3:59 PM
$VCEL dang, missed that bump
0 · Reply
Pro_From_Dover
Pro_From_Dover Dec. 19 at 9:32 PM
$VCEL forget the Santa Claus Rally- we got the Screwged Over Sweepstakes in VCEL land- happy day to all who celebrate!
1 · Reply
copperhat
copperhat Dec. 19 at 2:08 PM
$VCEL thank you truist securities for lowering pt the morning after. Probably not going to call either
1 · Reply